Abstract
Brain tumor imaging has evolved from a strictly morphologybased discipline to one that encompasses function, physiology, and anatomy, enabled by advances in imaging and computer technology. This review outlines the current imaging standard for patients with brain tumors and summarizes the latest advances in physiology-based imaging methods that complement traditional brain tumor imaging protocol. Emphasis is placed on the strengths and limitations of the current imaging standards and on an overview of several advanced imaging methods, including diffusion-weighted magnetic resonance imaging, perfusion magnetic resonance imaging, and proton magnetic resonance spectroscopic imaging. Basic physical principles behind each imaging method are briefly presented, along with a more in-depth discussion of the clinical applications and potential pitfalls of each technique.
Similar content being viewed by others
References and Recommended Reading
Burger PC, Vogel FS: The brain: tumors. In Surgical Pathology of the Central Nervous System and its Coverings. Edited by Burger PC, Vogel FS. New York: Wiley; 1982:223–266.
Burger PC, Vogel FS, Green SB, Strike TA: Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985, 56:1106–1111.
Kleihues P, Sobin LH: World Health Organization classification of tumors. Cancer 2000, 88:2887.
Kleihues P, Ohgaki H: Phenotype vs genotype in the evolution of astrocytic brain tumors. Toxicol Pathol 2000, 28:164–170.
Ricci PE: Imaging of adult brain tumors. Neuroimaging Clin North Am 1999, 9:651–669.
Felix R, Schorner W, Laniado M, et al.: Brain tumors: MR imaging with gadolinium-DTPA. Radiology 1985, 156:681–688.
Kates R, Atkinson D, Brant-Zawadzki M: Fluid-attenuated inversion recovery (FLAIR): clinical prospectus of current and future applications. Top Magn Reson Imaging 1996, 8:389–396.
Ercan N, Gultekin S, Celik H, et al.: Diagnostic value of contrast-enhanced fluid-attenuated inversion recovery MR imaging of intracranial metastases. Am J Neuroradiol 2004, 25:761–765.
Singer MB, Atlas SW, Drayer BP: Subarachnoid space disease: diagnosis with fluid-attenuated inversion-recovery MR imaging and comparison with gadolinium-enhanced spinecho MR imaging—blinded reader study. Radiology 1998, 208:417–422.
Edelman RR, Wielopolski P, Schmitt F: Echo-planar MR imaging. Radiology 1994, 192:600–612.
Castillo M, Mukherji SK: Diffusion-weighted imaging in the evaluation of intracranial lesions. Semin Ultrasound CT MR 2000, 21:405–416.
Schaefer PW, Grant PE, Gonzalez RG: Diffusion-weighted MR imaging of the brain. Radiology 2000, 217:331–345.
Holodny AI, Ollenschlager M: Diffusion imaging in brain tumors. Neuroimaging Clin North Am 2002, 12:107–124.
Ito R, Mori S, Melhem ER: Diffusion tensor brain imaging and tractography. Neuroimaging Clin North Am 2002, 12:1–19.
Rosen BR, Belliveau JW, Vevea JM, Brady TJ: Perfusion imaging with NMR contrast agents. Magn Res Med 1990, 14:249–265.
Weisskoff R, Belliveau J, Kwong K, Rosen B: Functional MR imaging of capillary hemodynamics. In Magnetic Resonance Angiography: Concepts and Applications. Edited by Potchen E. St. Louis, MO: Mosby; 1993:473–484.
Weisskoff RM, Rosen BR: Noninvasive determination of regional cerebral blood flow in rats using dynamic imaging with Gd(DTPA). Magn Reson Med 1992, 25:211–212.
Aronen HJ, Gazit IE, Louis DN, et al.: Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994, 191:41–51.
Knopp EA, Cha S, Johnson G, et al.: Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999, 211:791–798.
Sugahara T, Korogi Y, Kochi M, et al.: Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. Am J Roentgenol 1998, 171:1479–1486.
Sugahara T, Korogi Y, Shigematsu Y, et al.: Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. J Comput Assist Tomogr 1999, 23:232–237.
Cha S, Pierce S, Knopp EA, et al.: Dynamic contrast-enhanced t2*-weighted MR imaging of tumefactive demyelinating lesions. Am J Neuroradiol 2001, 22:1109–1116.
Burger PC, Vollmer RT: Histologic factors of prognostic significance in the glioblastoma multiforme. Cancer 1980, 46:1179–1186.
Kelly PJ, Daumas-Duport C, Scheithauer BE, et al.: Stereotactic histologic correlations of computed tomography and magnetic resonance imaging defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987, 62:450–459.
Valk PE, Dillon WP: Radiation injury of the brain. Am J Neuroradiol 1991, 12:45–62.
Ricci PE, Karis JP, Heiserman JE, et al.: Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? [see comments]. Am J Neuroradiol 1998, 19:407–413.
Vajkoczy P, Menger MD: Vascular microenvironment in gliomas. J Neurooncol 2000, 50:99–108.
Law M, Cha S, Knopp EA, et al.: High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002, 222:715–721.
Machein MR, Plate KH: VEGF in brain tumors. J Neuro-oncol 2000, 50:109–120.
Burtscher IM, Skagerberg G, Geijer B, et al.: Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. Am J Neuroradiol 2000, 21:84–93.
Li X, Lu Y, Pirzkall A, et al.: Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 2002, 16:229–237. This is an important study.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cha, S. Update on brain tumor imaging. Curr Neurol Neurosci Rep 5, 169–177 (2005). https://doi.org/10.1007/s11910-005-0044-x
Issue Date:
DOI: https://doi.org/10.1007/s11910-005-0044-x